Antibody Tests Identify COVID-19 From 2 to 3 Weeks After Symptoms
Antibody testing may detect SARS-CoV-2 infection, with sensitivity peaking at three weeks since symptom onset.
General Rheumatology
Treatment With DMARDs Does Not Alter COVID-19 Susceptibility and Severity
Researchers evaluated the risk for COVID-19 infection and its severity in patients receiving DMARDs.
CDC Updates List of Conditions With Highest Risk for COVID-19
The list of conditions that put people at risk for severe COVID-19 illness has been expanded by the US CDC.
Clinical Benefit Observed With Colchicine in Hospitalized Patients With COVID-19
Colchicine could potentially play a role in the treatment of hospitalized patients with COVID-19.
CDC: 10.7% of US Adults Used Prescription Pain Medications From 2015 to 2018
In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications.
Increased COVID-19 Hospitalization With Glucocorticoid Use in Rheumatic Disease
For patients with rheumatic disease with COVID-19, glucocorticoids are associated with increased odds of hospitalization.
Suicide Risk Increased After Hip Fracture in Elderly Patients
Elderly patients with hip fracture have an increased risk for suicide.
COVID-19 Vaccine May Be Available by Late 2020, Early 2021: Fauci
There could be a COVID-19 vaccine by the end of this year or early next year, according to Anthony Fauci, MD.
From Survive to Thrive: A Call to Action to Transform Rheumatology Patient Care During the COVID-19 Pandemic
In this perspective, S. Louis Bridges Jr, MD, PhD, provides insight into managing care for patients with rheumatic diseases during the COVID-19 pandemic.
Increased Risk for Inflammatory Arthritis in Patients With Newly Diagnosed Hidradenitis Suppurativa
Researchers assessed risk for inflammatory arthritis in patients with newly diagnosed hidradenitis suppurativa.
-
Loading...
-
Loading...
Next post in General Rheumatology
